Number of Targeted therapies targeting Oncology indications
Number of Targeted therapies targeting Oncology indications
Major development efforts are focused on rare and oncology indications
Major development efforts are focused on rare and oncology indications
Comparisons Between U.S. and EU Policies on Orphan Drugs
Comparisons Between U.S. and EU Policies on Orphan Drugs
USA: Approval of New Molecular Entity from 2001 to 2021
USA: Approval of New Molecular Entity from 2001 to 2021
Merger and Acquisition Deals by Therapeutic Area in Pharmaceutical and Healthcare Space (2018-2021)
Merger and Acquisition Deals by Therapeutic Area in Pharmaceutical and Healthcare Space (2018-2021)
EffRx Obtains Swiss Marketing Authorization for Bronchitol® in Cystic Fibrosis.
EffRx Pharmaceuticals SA, a commercial-stage company that commercializes niche and orphan medicines in Switzerland and Europe, announced today that Swissmedic had approved Bronchitol® (inhaled mannito ...